Current Opinion in Allergy and Clinical Immunology was launched in 2001. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of allergy and clinical immunology are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's and Section Editors for this issue.
Luigi D. Notarangelo
Luigi D. Notarangelo is Professor of Pediatrics and Pathology at the Harvard Medical School and Director of the Research and Molecular Diagnosis Program on Primary Immunodeficiencies in Boston, USA. He has served as President of the European Society for Immune Deficiencies (ESID) from 2002 to 2006 and co-chairs the International Union Immunological Societies Committee for classification of Primary Immunodeficiencies. He is the author of over 370 publications in peer-reviewed journals, most of which pertain to the characterization of the molecular and cellular basis of primary immune deficiencies. In particular, he has actively participated in the identification of the molecular and cellular defects involved in X-linked immunodeficiency with hyper-IgM, SCID due to JAK3 deficiency, Omenn syndrome, X-linked thrombocytopenia, and WHIM syndrome.
Thomas A. Fleisher
Thomas A. Fleisher, MD is the Chief of the Department of Laboratory Medicine in the Clinical Center at the National Institutes of Health (NIH) in Bethesda, MD, USA and directs the diagnostic immunology laboratory and training in laboratory immunology within this department. Dr Fleisher serves as an allergy consultant to the National Institutes of Allergy and Infectious Diseases at the NIH as well as an adjunct professor in the Department of Pediatrics at the Uniformed Services University of Health Sciences also in Bethesda. He received his pediatric training at the University of Minnesota and his allergy and immunology training at the NIH. His research interests focus on improved and expanded diagnostic methods for immunological disorders and evaluating the underlying immunopathogenic mechanisms that produce the clinical consequences of the autoimmune lymphoproliferative syndrome (ALPS). Dr Fleisher is currently President of the Robert A. Good Immunology Society as well as a past president of the Clinical Immunology Society and member of the Board of Directors of the American Academy of Allergy, Asthma and Immunology.
Dr Robert Bush received his MD degree from West Virginia University. After completing his residency in Internal Medicine and fellowship in Allergy and Immunology at the University of Wisconsin – Madison, he joined the faculty. He is currently Professor (Emeritus) of Medicine and is Chief of Allergy at the Wm.S. Middleton VA Hospital, Madison, Wisconsin. His research interests include sublingual immunotherapy, allergen characterization, fungal allergy, food allergy, and occupational asthma. He is certified by the American Board of Allergy and Immunology.
Dr Passalacqua was born in Genoa in 1964, graduated in 1990 from the Genoa University Medical School, Italy, and received the specialty degrees in Allergy and in Respiratory Medicine in 1994 and 2002. Under the chairmanship of Prof. Giorgio Walter Canonica, he contributed to investigate the mechanisms of allergic inflammation, the treatment of respiratory allergy and developed the sublingual immunotherapy. Currently he is Professor of Respiratory Medicine and allergy at the Respiratory Diseases Clinic of the University of Genoa. Dr Passalacqua has coauthored more than 200 publications in peer reviewed journals. He serves on the board of experts of Allergic Rhinitis and its Impact on Asthma (ARIA), is the chairman of the EAACI immunotherapy interest group and co-chairman of the immunotherapy committee of the World Allergy Organization.